Name | Description | Industry | Official Website | Location | ||
---|---|---|---|---|---|---|
Amgen Inc. (formerly Applied Molecular Genetics Inc.) is an American multinational biopharmaceutical company founded in 1980 with headquarters in Thousand Oaks, California. | ||||||
Atlas Venture creates and invests in biotech startup companies in the U.S. with seed and early stage venture investments. | ||||||
AbbVie was formed when Abbott separated into two companies where Abbott focuses on medical products and Abbvie is a research-based biopharmaceutical company. Abbvie was founded in 2013 and is headquartered in North Chicago, IL. | ||||||
AstraZeneca is a global biopharmaceutical business founded in 1999. | ||||||
Gilead Sciences is a research-based biopharmaceutical company developing and commercializing medicines founded in 1987 by Michael L. Riordan. | ||||||
Vertex Pharmaceuticals discovers, develops and commercializes pharmaceutical products for treatment of cystic fibrosis, cancer, inflammatory bowel, autoimmune disease and neurological disorders. | ||||||
Cabaletta Bio is a biotechnology company developing cellular therapies for autoimmune disease. | ||||||
Celgene discovers, develops and commercializes innovative therapies to treat cancer and immune-inflammatory-related diseases. | ||||||
A biopharmaceutical company developing treatments for B-cell malignancies and autoimmune diseases | ||||||
Seagen is a Bothell, Washington-based company developing antibody-based therapies for the treatment of cancer and autoimmune diseases. | ||||||
Rubius Therapeutics is a biotechnology company using stem cells to develop red blood cell cellular therapies. | ||||||
A clinical-stage biopharmaceutical company engaging in drug discovery and drug development for treating autoimmune disease and cancer. | ||||||
Intellia Therapeutics is a biotechnology company founded in 2014, based in Cambridge, MA that develops biopharmaceuticals using CRISPR-Cas9 gene editing technology. | ||||||
A pharmaceutical company developing treatments for cancer and chronic diseases. It was founded in 2006 and is located in San Diego, California. | ||||||
Aria Pharmaceuticals is a first-in-class pharmaceutical discovery and development founded in 2014 by Andrew M. Radin. | ||||||
A company developing antibody-based biological medicines for kidney diseases and other chronic diseases. Visterra was acquired by Otsuka Pharmaceutical in 2018. | ||||||
Antidote.me closes the gap between clinical trials and patients | ||||||
A biotechnology company developing engineered cell therapies for treating diseases in neurology, cardiology and autoimmunity. | ||||||
Cel-Sci is a company that develops biotechnology immunotherapy products for the treatment of cancer and other infectious diseases | ||||||
A global biopharmaceutical company focused on the discovery and development of small-molecule drugs. | ||||||
A biotechnology that specializes in genome editing, gene therapy, cell therapy and gene regulation. | ||||||
A biotechnology company founded in 2015 which operates as a subsidiary of Gilead Sciences and Kite Pharma. The company developed a platform for custom cell engineering called synNotch to be used for anticancer therapies. Their system can also be used to develop cell-based therapies for autoimmune and degenerative disorders. | ||||||
A company developing therapies for the treatment of cancer and immune disorders | ||||||
A biopharmaceutical company that researches and develops products to prevent infectious disease and treat autoimmune and inflammatory diseases. It was founded in 1996 and is located in Berkeley, California. | ||||||
A company developing immunotherapy treatments for cancers, infectious and autoimmune diseases |